Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease. (Q48203927)
Jump to navigation
Jump to search
scientific article published on 23 February 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease. |
scientific article published on 23 February 2017 |
Statements
Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease (English)
G R van den Brink
C Ponsioen
R Mathot
M Löwenberg